| 83.78 -0.56 (-0.66%) | 12-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 100.96 | 1-year : | 104.45 |
| Resists | First : | 86.43 | Second : | 89.43 |
| Pivot price | 83.94 |
|||
| Supports | First : | 81.59 | Second : | 67.89 |
| MAs | MA(5) : | 84.31 |
MA(20) : | 83.96  |
| MA(100) : | 89.09 |
MA(250) : | 0 | |
| MACD | MACD : | -0.5 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 30.5 |
D(3) : | 37.7 |
| RSI | RSI(14): 45.4 |
|||
| 52-week | High : | 105.55 | Low : | 71.41 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LMAT ] has closed above bottom band by 44.7%. Bollinger Bands are 64% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 84.85 - 85.32 | 85.32 - 85.71 |
| Low: | 81.71 - 82.39 | 82.39 - 82.93 |
| Close: | 82.79 - 83.79 | 83.79 - 84.6 |
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Sun, 21 Dec 2025
LeMaitre Vascular (NASDAQ:LMAT) Hasn't Managed To Accelerate Its Returns - Yahoo Finance
Sun, 21 Dec 2025
Congress Asset Management Co. Has $60.58 Million Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Fri, 19 Dec 2025
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Sat, 13 Dec 2025
LeMaitre Vascular, Inc. $LMAT Shares Sold by AWM Investment Company Inc. - MarketBeat
Sat, 13 Dec 2025
Wells Fargo Sticks to Their Hold Rating for Lemaitre Vascular (LMAT) - The Globe and Mail
Thu, 06 Nov 2025
LeMaitre Vascular Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 23 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 7.9 (%) |
| Held by Institutions | 95 (%) |
| Shares Short | 1,080 (K) |
| Shares Short P.Month | 1,220 (K) |
| EPS | 2.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.7 |
| Profit Margin | 22.1 % |
| Operating Margin | 33.2 % |
| Return on Assets (ttm) | 7.9 % |
| Return on Equity (ttm) | 15 % |
| Qtrly Rev. Growth | 11.3 % |
| Gross Profit (p.s.) | 7.53 |
| Sales Per Share | 10.61 |
| EBITDA (p.s.) | 3.18 |
| Qtrly Earnings Growth | 53.5 % |
| Operating Cash Flow | 73 (M) |
| Levered Free Cash Flow | 45 (M) |
| PE Ratio | 36.11 |
| PEG Ratio | 0 |
| Price to Book value | 5.01 |
| Price to Sales | 7.89 |
| Price to Cash Flow | 25.94 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|